Drug reimbursement recommendations by the National Institute for Health and Clinical Excellence: Have they impacted the National Health Service budget?

Health Policy ◽  
2013 ◽  
Vol 110 (1) ◽  
pp. 49-59 ◽  
Author(s):  
Josephine Mauskopf ◽  
Costel Chirila ◽  
Julie Birt ◽  
Kristina S. Boye ◽  
Lee Bowman
Keyword(s):  
National Health Service ◽  
Health Service ◽  
National Health ◽  
Clinical Excellence ◽  
Drug Reimbursement

Rewarding clinical excellence in the National Health Service

2010 ◽  
Vol 1 (2) ◽  
pp. 67-70
Author(s):  
Warren Jones
Keyword(s):  
National Health Service ◽  
Health Service ◽  
Advisory Committee ◽  
National Health ◽  
Clinical Excellence

This article is intended to provide an improved understanding of how the Clinical Excellence Awards (CEA) scheme works in England.The author was a member of the Cheshire and Mersey sub-committee from 2003–2009, the last 3 years being medical vice-chair.While the views represented within this article are intended to be as accurate as possible and are based on his experience, they are personal to the author, who no longer has any official role in the Advisory Committee on Clinical Excellence Awards (ACCEA) and do not necessarily represent the views of ACCEA.The official guide to the scheme is available at < http://www.dh.gov.uk/ab/ACCEA/index.htm >.

scholarly journals Assessing the impact of England's National Health Service R&D Health Technology Assessment program using the “payback” approach

2009 ◽  
Vol 25 (01) ◽  
pp. 1-5 ◽  
Author(s):  
James Raftery ◽  
Stephen Hanney ◽  
Colin Green ◽  
Martin Buxton
Keyword(s):  
National Health Service ◽  
Health Service ◽  
Health Technology Assessment ◽  
Case Studies ◽  
National Health ◽  
Technology Assessment ◽  
Clinical Excellence ◽  
Health Technology ◽  
The Mean ◽  
The Impact

Objectives:This study assesses the impact of the English National Health Service (NHS) Health Technology Assessment (HTA) program using the “payback” framework.Methods:A survey of lead investigators of all research projects funded by the HTA program 1993–2003 supplemented by more detailed case studies of sixteen projects.Results:Of 204 eligible projects, replies were received from 133 or 65 percent. The mean number of peer-reviewed publications per project was 2.9. Seventy-three percent of projects claimed to have had had an impact on policy and 42 percent on behavior. Technology Assessment Reports for the National Institute for Health and Clinical Excellence (NICE) had fewer than average publications but greater impact on policy. Half of all projects went on to secure further funding. The case studies confirmed the survey findings and indicated factors associated with impact.Conclusions:The HTA program performed relatively well in terms of “payback.” Facilitating factors included the program's emphasis on topics that matter to the NHS, rigorous methods and the existence of “policy customers” such as NICE.

scholarly journals Guidelines for the management of depression: NICE work?

2010 ◽  
Vol 197 (5) ◽  
pp. 345-347 ◽  
Author(s):  
Tony Kendrick ◽  
Robert Peveler
Keyword(s):  
National Health Service ◽  
Health Service ◽  
National Health ◽  
Secondary Care ◽  
Clinical Excellence ◽  
Physical Illness ◽  
Care Services

SummaryThe National Institute for Health and Clinical Excellence (NICE) recently updated its guidance on managing depression, adding specific guidance for depression in people with physical illness. The guidance should help improve the targeting of treatments, although implementation of the guidance on depression in physical illness is challenging in the National Health Service (NHS) context of separate primary and secondary care services.

Reallocating resources: how should the National Institute for Health and Clinical Excellence guide disinvestment efforts in the National Health Service?

2007 ◽  
Vol 12 (3) ◽  
pp. 160-165 ◽  
Author(s):  
Steven Pearson ◽  
Peter Littlejohns
Keyword(s):  
National Health Service ◽  
Health Service ◽  
National Health ◽  
Public Support ◽  
Clinical Excellence ◽  
Cost Effective ◽  
Department Of Health ◽  
The Face ◽  
Primary Focus ◽  
English National Health

The recent acute budgetary pressures within the English National Health Service (NHS) have accentuated calls for targeted disinvestment thereby eliminating ineffective or low-value services to provide resources that can be reallocated toward more cost-effective purposes. This challenge extends beyond allocating new resources wisely, a goal that has been, since its inception, the primary focus of the National Institute for Health and Clinical Excellence (NICE). But on 6 September 2006, the Department of Health announced a new mandate for NICE to help the NHS identify interventions that are not effective. This paper discusses current NICE efforts to support value in the NHS and then explores the policy options available to the Institute as it prepares to launch a programme to meet the NHS request for guidance on disinvestment. All of the possible options present challenges. NICE will need to collaborate in new ways with partners inside, and perhaps outside, the NHS. However, the Institute has an established reputation for rigour, transparency and political durability that makes it well qualified to sustain public support in the face of difficult decisions. Disinvestment will provide a stern test of these qualities.

scholarly journals Clinical Guidelines in Mental Health I: the National Collaborating Centre for Mental Health

2004 ◽  
Vol 28 (5) ◽  
pp. 156-159 ◽  
Author(s):  
Tim Kendall ◽  
Steve Pilling ◽  
Catherine Pettinari ◽  
Craig Whittington
Keyword(s):  
Mental Health ◽  
Mental Illness ◽  
National Health Service ◽  
Health Service ◽  
National Health ◽  
Clinical Guidelines ◽  
Clinical Guideline ◽  
Mental Health Problems ◽  
Clinical Excellence ◽  
Severe Form

The first national clinical guideline for the National Health Service (NHS) was produced by the National Collaborating Centre for Mental Health (NCCMH) for the National Institute for Clinical Excellence (NICE) and launched in December 2002. That the first guideline to emerge was a guideline in mental health was important. Furthermore, that the guideline was about the treatment of the most severe form of mental illness, schizophrenia, has drawn a great deal of attention to the plight of people with mental health problems, both within NICE, its Citizens Council and Partners Council, and in the medical press (Battacharya & Gough, 2002; Mayor, 2002; Hargreaves, 2003).

Litigation claims relating to venous thromboembolism in the NHS

2014 ◽  
Vol 30 (6) ◽  
pp. 389-396 ◽  
Author(s):  
Victoria White ◽  
Alexander Nath ◽  
Gerard Stansby
Keyword(s):  
Patient Outcome ◽  
Venous Thromboembolism ◽  
National Health Service ◽  
Health Service ◽  
National Health ◽  
Financial Burden ◽  
Clinical Excellence ◽  
Improve Patient Outcome ◽  
Vein Thrombosis ◽  
Improve Patient

Aim Litigation costs for clinical negligence in the management of venous thromboembolism have escalated in the last five years. The National Health Service Litigation Authority estimates these claims have cost in excess of £112 million. Our aim is to identify the areas of practice where these claims are most likely to arise to help improve patient outcome. Methods The National Health Service Litigation Authority provided de-identified data on individual medical negligence claims against the NHS since 2007. We subcategorised the data into (a) the nature of the venous thromboembolism event, (b) the area of specialist practice and (c) the damages incurred. Inter-group differences were evaluated using ANOVA, Kruskal–Wallis test and Mann–Whitney U Test. Results Failure to prevent and to diagnose pulmonary emboli and deep vein thrombosis occurs across the spectrum of clinical specialties. In the study period 189 claims were made. The majority of claims were in surgical specialties and the financial burden was significantly greater than in the medical specialities (£3,257,394 vs. £1,532,996). The amounts paid out by specialty was not significantly different but had significant variance ( p < 0.0001). Conclusions The National Institute of Clinical Excellence provides comprehensive guidelines on venous thromboembolism risk assessment. Poor compliance has contributed to morbidity and mortality while the cost has continued to escalate. A multimodal approach to education is needed to improve patient outcome. Improved venous thromboembolism prevalence data are also needed.

scholarly journals Pre-habilitation for patients awaiting total knee replacement in the United Kingdom National Health Service: A review of publicly facing information

2021 ◽  
pp. 1-7
Author(s):  
Gareth Stephens ◽  
Ahmed Maarabouni ◽  
Gemma Mansell ◽  
Chris Littlewood
Keyword(s):  
National Health Service ◽  
Health Service ◽  
Total Knee Replacement ◽  
Knee Replacement ◽  
National Health ◽  
Controlled Trial ◽  
Clinical Excellence ◽  
Future Research ◽  
Total Knee ◽  
The Uk

INTRODUCTION: Approximately 14,000 –21,500 individuals per year are dissatisfied with the outcome of their Total Knee Replacement (TKR) in the UK National Health Service (NHS). National Institute of Clinical Excellence (NICE) guidelines recommend that future research should evaluate whether a ‘full programme of pre-habilitation’ can improve outcomes for patients awaiting TKR. The aim of this review was to describe current pre-habilitation practice for patients awaiting TKR in the UK NHS, to inform future research. METHODS: Two reviewers independently undertook electronic searches for publicly available information sheets (PIS) from websites of UK NHS Trusts that included detail about pre-habilitation for patients awaiting TKR. One reviewer extracted data, and a second reviewer verified this. RESULTS: Fifty PIS, nine information videos and one web page from 59 NHS Trusts were identified. NHS Trusts most commonly provide patients with advice on pre-operative rehabilitation via a single appointment, combined with a PIS (36/59; 61.0%). NHS Trusts use appointments, PIS and video to provide patients awaiting TKR with information regarding pain control (46/58; 79.3%), exercise therapy (46/58; 79.3%), what to expect on the day of surgery and in-patient stay (58/58; 100%), lifestyle interventions (27/58; 46.6%), and adverse events (44/58; 75.9%). CONCLUSION: NHS Trusts commonly provided patients awaiting TKR with ‘advice on pre-operative rehabilitation’, however no NHS Trust provided a comprehensive programme of pre-habilitation. The results of this study will inform the development of a comprehensive, multi-modal pre-habilitation programme, to be tested in a future high-quality randomised controlled trial.

scholarly journals Extortion and the Ethics of “Topping Up”

2009 ◽  
Vol 18 (4) ◽  
pp. 443-445
Author(s):  
BENJAMIN SACHS
Keyword(s):  
Lung Cancer ◽  
National Health Service ◽  
Health Service ◽  
National Health ◽  
Clinical Excellence ◽  
Cost Effective ◽  
Point Of View ◽  
Free Treatment ◽  
Ethical Point ◽  
Out Of Pocket Payments

In November 2008 Professor Mike Richards issued his much awaited review of the British Department of Health's policy on out-of-pocket payments (“top-ups”) for drugs not approved as cost effective by the National Institute for Health and Clinical Excellence (NICE). The policy stated, or had been construed as stating, that those who top up thereby became ineligible for further National Health Service (NHS) treatment for the condition targeted by the drug. For instance, if a lung cancer sufferer bought Avastin, which is not NICE approved, she could no longer receive free treatment for her cancer on the NHS's tab. Richards, the National Cancer Director, recommended that the policy be repealed. From an ethical point of view, this change should be enthusiastically welcomed.

Sign in / Sign up

Export Citation Format

Share Document